Transjugular Intrahepatic Portosystemic Shunt

TIPS lowers portal pressure by providing an alternate route around increased resistance within the liver. Portal blood can then move into the systemic circulation rather than remaining under elevated pressure in the portal system. This pressure reduction helps address complications such as recurrent variceal bleeding and refractory ascites, which can become serious in advanced liver disease.

The shunt changes normal circulation by allowing portal blood to bypass part of the liver before entering the systemic circulation. Because this altered routing affects how blood moves through the liver, it may contribute to hepatic encephalopathy. This possibility is an important clinical consideration when the pressure-lowering benefits of the procedure are weighed against its effects on circulation.

The stent is placed across the liver tissue to keep the newly created channel open between the portal and hepatic veins. Its position supports continued blood flow through the bypass route, allowing the pressure-reducing connection to function after the catheter-based intervention. The stent therefore provides the structural pathway required for the shunt to produce its intended circulatory effect.

An interventional radiologist guides a catheter through the jugular vein toward the liver. Using this minimally invasive route, the specialist creates a channel across the liver tissue between the portal and hepatic veins, then places a stent in that channel. This approach establishes the bypass without requiring an open surgical access route through the liver.

Clinicians use TIPS to manage complications of portal hypertension, particularly recurrent variceal bleeding and refractory ascites. The procedure is especially relevant in advanced liver disease, where increased portal pressure can produce difficult-to-control complications. By reducing that pressure, the intervention may help control events that are otherwise potentially life-threatening.

The principal benefit is improved blood flow through a lower-pressure pathway, which can help control recurrent variceal bleeding or refractory ascites. However, redirecting portal blood into the systemic circulation alters normal hepatic circulation and may contribute to hepatic encephalopathy. TIPS therefore provides an important therapeutic option while requiring attention to its potential neurological consequence.